公开(公告)号：US20230052629A1

公开(公告)日：2023-02-16

申请号：US17352734

申请日：2021-06-21

Applicant: Novartis AG

Inventor： Christopher Becker ,  Xiaolin Li ,  Peichao Lu ,  Naomi Samadara Rajapaksa ,  David Charles Tully ,  Xiaojing Michael Wang ,  Qian Zhao

IPC: C07D471/04 ,  A61P31/22

Abstract: The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

公开(公告)号：US20200079772A1

公开(公告)日：2020-03-12

申请号：US16569107

申请日：2019-09-12

Applicant: Novartis AG

Inventor： Christopher Becker ,  Xiaolin Li ,  Peichao Lu ,  Naomi Samadara Rajapaksa ,  David Charles Tully ,  Xiaojing Michael Wang ,  Qian Zhao

IPC: C07D471/04 ,  A61P31/22

Abstract: The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.

公开(公告)号：US11072610B2

公开(公告)日：2021-07-27

申请号：US16569107

申请日：2019-09-12

Applicant: Novartis AG

Inventor： Christopher Becker ,  Xiaolin Li ,  Peichao Lu ,  Naomi Samadara Rajapaksa ,  David Charles Tully ,  Xiaojing Michael Wang ,  Qian Zhao

IPC: C07D471/04 ,  A61P31/22

Abstract: The invention provides compounds of Formula (I) as described herein, along with pharmaceutically acceptable salts, pharmaceutical compositions containing such compounds, and methods to use these compounds, salts and compositions for treating viral infections, particularly infections caused by herpesviruses.